These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30430199)

  • 1. Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcoma.
    Buondonno I; Gazzano E; Tavanti E; Chegaev K; Kopecka J; Fanelli M; Rolando B; Fruttero R; Gasco A; Hattinger C; Serra M; Riganti C
    Cell Mol Life Sci; 2019 Feb; 76(3):609-625. PubMed ID: 30430199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenografts.
    Gazzano E; Buondonno I; Marengo A; Rolando B; Chegaev K; Kopecka J; Saponara S; Sorge M; Hattinger CM; Gasco A; Fruttero R; Brancaccio M; Serra M; Stella B; Fattal E; Arpicco S; Riganti C
    Cancer Lett; 2019 Aug; 456():29-39. PubMed ID: 31047947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer.
    Salaroglio IC; Gazzano E; Abdullrahman A; Mungo E; Castella B; Abd-Elrahman GEFA; Massaia M; Donadelli M; Rubinstein M; Riganti C; Kopecka J
    J Exp Clin Cancer Res; 2018 Nov; 37(1):286. PubMed ID: 30482226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma.
    Buondonno I; Gazzano E; Jean SR; Audrito V; Kopecka J; Fanelli M; Salaroglio IC; Costamagna C; Roato I; Mungo E; Hattinger CM; Deaglio S; Kelley SO; Serra M; Riganti C
    Mol Cancer Ther; 2016 Nov; 15(11):2640-2652. PubMed ID: 27466354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sdox, a H
    Durante M; Frosini M; Chiaino E; Fusi F; Gamberucci A; Gorelli B; Chegaev K; Riganti C; Saponara S
    Vascul Pharmacol; 2022 Apr; 143():106969. PubMed ID: 35149209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin reverses tunicamycin-induced endoplasmic reticulum stress in human hepatocellular carcinoma cells and improves cytotoxic response to doxorubicin by increasing CHOP and decreasing survivin.
    Fan L; Sun G; Ma T; Zhong F; Lei Y; Li X; Wei W
    J Pineal Res; 2013 Sep; 55(2):184-94. PubMed ID: 23711089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
    Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
    J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitizing osteosarcoma stem cells to doxorubicin-induced apoptosis through retention of doxorubicin and modulation of apoptotic-related proteins.
    Gonçalves C; Martins-Neves SR; Paiva-Oliveira D; Oliveira VE; Fontes-Ribeiro C; Gomes CM
    Life Sci; 2015 Jun; 130():47-56. PubMed ID: 25818183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comprehensive Evaluation of Sdox, a Promising H
    Alov P; Al Sharif M; Aluani D; Chegaev K; Dinic J; Divac Rankov A; Fernandes MX; Fusi F; García-Sosa AT; Juvonen R; Kondeva-Burdina M; Padrón JM; Pajeva I; Pencheva T; Puerta A; Raunio H; Riganti C; Tsakovska I; Tzankova V; Yordanov Y; Saponara S
    Front Pharmacol; 2022; 13():831791. PubMed ID: 35321325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoplasmic reticulum stress-induced resistance to doxorubicin is reversed by paeonol treatment in human hepatocellular carcinoma cells.
    Fan L; Song B; Sun G; Ma T; Zhong F; Wei W
    PLoS One; 2013; 8(5):e62627. PubMed ID: 23658755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of C/EBP-β LIP in multidrug resistance.
    Riganti C; Kopecka J; Panada E; Barak S; Rubinstein M
    J Natl Cancer Inst; 2015 Mar; 107(5):. PubMed ID: 25766403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Icariin enhances cytotoxicity of doxorubicin in human multidrug-resistant osteosarcoma cells by inhibition of ABCB1 and down-regulation of the PI3K/Akt pathway.
    Wang Z; Yang L; Xia Y; Guo C; Kong L
    Biol Pharm Bull; 2015; 38(2):277-84. PubMed ID: 25747987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human Osteosarcoma.
    Belisario DC; Akman M; Godel M; Campani V; Patrizio MP; Scotti L; Hattinger CM; De Rosa G; Donadelli M; Serra M; Kopecka J; Riganti C
    Cells; 2020 Mar; 9(3):. PubMed ID: 32155954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotoxicity of doxorubicin and surface expression of P-glycoprotein (MDR1) is regulated by the Pseudomonas aeruginosa toxin Cif.
    Ye S; MacEachran DP; Hamilton JW; O'Toole GA; Stanton BA
    Am J Physiol Cell Physiol; 2008 Sep; 295(3):C807-18. PubMed ID: 18650266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma.
    Susa M; Iyer AK; Ryu K; Hornicek FJ; Mankin H; Amiji MM; Duan Z
    BMC Cancer; 2009 Nov; 9():399. PubMed ID: 19917123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel p97/VCP inhibitor induces endoplasmic reticulum stress and apoptosis in both bortezomib-sensitive and -resistant multiple myeloma cells.
    Nishimura N; Radwan MO; Amano M; Endo S; Fujii E; Hayashi H; Ueno S; Ueno N; Tatetsu H; Hata H; Okamoto Y; Otsuka M; Mitsuya H; Matsuoka M; Okuno Y
    Cancer Sci; 2019 Oct; 110(10):3275-3287. PubMed ID: 31368616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein.
    Abd-Ellatef GEF; Gazzano E; El-Desoky AH; Hamed AR; Kopecka J; Belisario DC; Costamagna C; S Marie MA; Fahmy SR; Abdel-Hamid AZ; Riganti C
    Pharmacol Res; 2022 Jan; 175():105975. PubMed ID: 34785319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tributyltin-induced endoplasmic reticulum stress and its Ca(2+)-mediated mechanism.
    Isomura M; Kotake Y; Masuda K; Miyara M; Okuda K; Samizo S; Sanoh S; Hosoi T; Ozawa K; Ohta S
    Toxicol Appl Pharmacol; 2013 Oct; 272(1):137-46. PubMed ID: 23743301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy.
    Salaroglio IC; Panada E; Moiso E; Buondonno I; Provero P; Rubinstein M; Kopecka J; Riganti C
    Mol Cancer; 2017 May; 16(1):91. PubMed ID: 28499449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New NO- and H2S-releasing doxorubicins as targeted therapy against chemoresistance in castration-resistant prostate cancer: in vitro and in vivo evaluations.
    Bigagli E; Luceri C; De Angioletti M; Chegaev K; D'Ambrosio M; Riganti C; Gazzano E; Saponara S; Longini M; Luceri F; Cinci L
    Invest New Drugs; 2018 Dec; 36(6):985-998. PubMed ID: 29607467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.